Skip to main content
. 2015 Apr 2;8(1):11. doi: 10.1186/s40413-015-0062-3

Table 1.

Patients’ characteristics

Total (n = 77) Pranlukast (n = 37) Placebo (n = 40) P value
Age (y), mean (SD) 1.9 ± 0.6 1.8 ± 0.5 1.9 ± 0.6 0.71*1
Males, no. (%) 56 (73) 29 (78) 27 (68) 0.28*2
Comorbidity*3
Food allergy, no. (%) 39 (51) 20 (54) 19 (48) 0.57*2
Atopic dermatitis, no. (%) 32 (42) 14 (38) 18 (45) 0.52*1
Total IgE (IU), median (25% – 75%) 214 (76 – 585) 224 (64 – 536) 204 (106 – 771) 0.77*4
Allergen-specific IgE (IU), median (25% – 75%)
Mite 5.8 (0.4 – 49) 5.6 (0.4 – 48) 6.1 (0.3 – 49) 0.42*4
Egg 5.6 (1.1 – 26) 12 (0.9 – 29) 3.2 (1.3 – 15) 0.26*4
Milk 0.7 (0. 4 – 4.3) 1.3 (0.4 – 9.9) 0.7 (0.4 – 2.5) 0.34*4
Wheat 0.6 (0.3 – 3.1) 0.5 (0.3 – 3.5) 0.7 (0.3 – 2.2) 0.96*4
Eosinophils (%), median (25% – 75%) 3.6 (1.4 – 5.0) 4.0 (1.4 – 5.0) 3.3 (1.0 – 5.0) 0.71*4

*1P value was calculated by Student’s t-test. *2P value was calculated by the χ2 test. *3Comorbidity was diagnosed by collaborating pediatricians. *4P value was calculated by the Mann–Whitney test.